← Leaderboards
James Homans
University Of Southern California
$135,753
Attributed
$135,753
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $45.4K · FY2005–06$50K$37.5K$25K$12.5K$0
'05
'06
Funding mix
By agency
NIH$135,753 · 5
By mechanism
M01$135,753 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Stephen A. Stohlman$10,842,155
- Don J Diamond$24,317,616
- Andrea A. Kovacs$11,647,115
- Michael G Dube$1,076,796
- Alexandra M Levine$34,706,653
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchAntiaids AgentCytotoxic T LymphocyteHelper T LymphocyteHiv InfectionsHuman SubjectImmune ResponseImmunopharmacologyLeukocyte Activation /TransformationPreschool Child (1-5)Streptococcus Pneumoniae VaccineVaccine EvaluationAids TherapyVirus Load
Grant awards (8)
INTENSIFICATION OF HIV-SPECIFIC CD4 AND CD8 ACTIVITY BY CYCLING HIGHLY ACTIVE$24,231
M01 · FY2006 · RR · contact PI
PREVALENCE OF MORPHOLOGIC AND METABOLIC ABNORMALITIES IN VERTICALLY HIV-INFECTED$15,145
M01 · FY2006 · RR · contact PI
PREVALENCE OF MORPHOLOGIC AND METABOLIC ABNORMALITIES IN HIV INFECTED$6,060
M01 · FY2006 · RR · contact PI
INTENSIFICATION OF HIV-SPECIFIC CD4 AND CD8 ACTIVITY BY CYCLING HIGHLY ACTIVE$19,362
M01 · FY2005 · RR
PREVALENCE OF MORPHOLOGIC AND METABOLIC ABNORMALITIES IN VERTICALLY HIV-INFECTED$6,454
M01 · FY2005 · RR
EVALUATION OF THE IMMUNOGENICITY OF PNEUMOCOCCAL CONJUGATE VACCINE AND ROUTINE$6,454
M01 · FY2005 · RR
INTENSIFICATION OF HIV-SPECIFIC CD4 AND CD8 ACTIVITY$34,396
M01 · FY2004 · RR
EVALUATION OF THE IMMUNOGENICITY OF PNEUMONOCCOCAL$23,651
M01 · FY2004 · RR